Skip to Main Content

Paper Details

Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium.
Pediatr Blood Cancer
7
2020
EWSR1, EwS, EwS cell lines, Ewing sarcoma, FLI1, MLL1, MV4;11, VTP-50469, menin, mixed lineage leukemia (MLL), mixed lineage leukemia (MLL)-rearranged leukemia cell line, tumor
Author NameAffiliation
Raushan T KurmashevaGreehey Children's Cancer Research Institute
Gerard M McGeehanSyndax Pharmaceuticals
Malcolm A Smith
Malcolm A Smith
Peter J HoughtonGreehey Children's Cancer Research Institute
  • 1 - 5

Datasets

Release 1.2